Indian authorities have allegedly proposed a significant reduction in tariffs across the board in exchange for relief from President Donald Trump’s tariffs to finalize a bilateral trade agreement.
According to Indian sources, Reuters reported that this plan aims to lower the average tariff gap between Indian and U.S. exports from 13% to 4%. Current figures from the World Trade Organization (WTO) indicate that India’s average tariff stands at 17%, while the U.S. average is only 3.3% as of 2023.
India’s strategy includes eliminating U.S. import obligations for certain goods and offering “priority access” for nearly 90% of U.S. imports. Items like aircraft, cars, communication technologies, medical devices, wine, and animal feed currently face minimal restrictions.
Additionally, India seeks priority access to key exports to the U.S., such as gems, clothing, textiles, chemicals, and agricultural products. There’s also interest in acquiring advanced U.S. technologies, particularly in computer chips, artificial intelligence, and pharmaceuticals.
With a trade surplus of $45.7 billion with the U.S., India has been under scrutiny from the Trump administration, which has criticized the significant trade imbalance and alleged unfair treatment by other nations. To address ongoing trade deficits, Trump introduced a 26% tariff on India, alongside a basic 10% tariff applicable to many countries.
Last month, the president temporarily halted plans for increased tariffs for 90 days, creating a window that India seems eager to utilize for a substantial trade agreement before the exemption lapses.
Indian officials indicated to Reuters that India and Japan are next in line to negotiate deals following the UK, and the announcement of the first successor trade agreement with the U.S. is anticipated soon.
According to Bloomberg News, recent discussions have included potential “zero-zero” tariffs on certain categories, such as steel, auto parts, and pharmaceuticals. The U.S. is also advocating for India to adopt higher quality control standards for imported medical devices and chemicals, which American companies consider unclear and unfair.
CNBC highlighted that analysts believe India often favors its domestic industries, yet there is a desire to settle tariff disagreements to swiftly engage in bilateral operations, secure access to the U.S. market, and attract global investments necessary for ambitious growth objectives.
Analysts on CNBC remarked that the “zero-zero-zero” proposal is particularly noteworthy given India’s hesitance to drastically lower its tariffs.
Some analysts pointed out that certain products mentioned in the Bloomberg report are significantly impacted by U.S. steel imports, while American pharmaceuticals are too costly for the average Indian consumer, resulting in high transportation costs and making a zero-tariff arrangement appealing.
Meanwhile, U.S. automakers have struggled to penetrate the Indian market, as there’s a noticeable preference for what are often termed “affordable Indian cars,” a reference to vehicles produced by companies like Tata Motors.
